Roland Eid

802 total citations
30 papers, 479 citations indexed

About

Roland Eid is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Roland Eid has authored 30 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Roland Eid's work include Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Roland Eid is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Roland Eid collaborates with scholars based in Lebanon, France and Egypt. Roland Eid's co-authors include Hampig Raphaël Kourié, Fadi Haddad, Matteo Lambertini, Khalil Saleh, Joseph Kattan, Frank H. Ruddle, Charles J. Bieberich, Klaus Schughart, Elissar Moujaess and David Planchard and has published in prestigious journals such as Journal of Clinical Oncology, Development and Annals of Oncology.

In The Last Decade

Roland Eid

27 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roland Eid Lebanon 11 242 192 154 81 54 30 479
Takao Miyabayashi Japan 7 239 1.0× 155 0.8× 141 0.9× 81 1.0× 63 1.2× 15 477
Duygu Derin Türkiye 12 181 0.7× 178 0.9× 79 0.5× 81 1.0× 60 1.1× 24 424
Hui Jun Lim Singapore 10 149 0.6× 273 1.4× 86 0.6× 97 1.2× 42 0.8× 26 497
Xianli He China 10 142 0.6× 242 1.3× 96 0.6× 143 1.8× 37 0.7× 19 469
Yinlu Ding China 15 151 0.6× 305 1.6× 91 0.6× 96 1.2× 45 0.8× 33 559
Stéphane Thibault United States 10 248 1.0× 168 0.9× 160 1.0× 116 1.4× 55 1.0× 16 462
Joanne Chiu China 13 241 1.0× 123 0.6× 155 1.0× 89 1.1× 22 0.4× 52 516
Lana Hamieh United States 13 238 1.0× 225 1.2× 167 1.1× 120 1.5× 38 0.7× 22 484
Marko Kornmann Germany 10 178 0.7× 179 0.9× 63 0.4× 78 1.0× 40 0.7× 26 375

Countries citing papers authored by Roland Eid

Since Specialization
Citations

This map shows the geographic impact of Roland Eid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Eid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Eid more than expected).

Fields of papers citing papers by Roland Eid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Eid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Eid. The network helps show where Roland Eid may publish in the future.

Co-authorship network of co-authors of Roland Eid

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Eid. A scholar is included among the top collaborators of Roland Eid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Eid. Roland Eid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eid, Roland, Pierre Decazes, C. David, et al.. (2025). Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients. Future Oncology. 21(6). 691–697.
3.
Eid, Roland, et al.. (2023). Acquired resistance mechanisms to osimertinib: The constant battle. Cancer Treatment Reviews. 116. 102557–102557. 41 indexed citations
4.
Haddad, Sara F., et al.. (2021). Awareness about the human papillomavirus (HPV) and HPV vaccine among medical students in Lebanon. Journal of Medical Virology. 94(6). 2796–2801. 14 indexed citations
5.
Haddad, Fadi, et al.. (2021). The combination of immune checkpoint inhibitors and chemotherapy in advanced non-small-cell lung cancer: the rational choice. Immunotherapy. 14(2). 155–167. 10 indexed citations
6.
Eid, Roland, et al.. (2020). L’attitude des médecins libanais vis-à-vis du dépistage du cancer de la prostate. Bulletin du Cancer. 107(11). 1199–1201. 2 indexed citations
7.
Haddad, Fadi, et al.. (2020). The Opinion of Oncologists on the Practice of Hypnosis among Cancer Patients in Lebanon. Complementary Therapies in Medicine. 53. 102534–102534. 4 indexed citations
8.
Eid, Roland, et al.. (2020). Epidemiologic and histologic characteristics of CNS lesions: a 20-year experience of a tertiary center in Lebanon. CNS Oncology. 9(2). CNS55–CNS55. 1 indexed citations
9.
Jalkh, Nadine, Roland Eid, Fadi Haddad, et al.. (2019). Results of NGS panel of hereditary breast and ovarian cancer in Lebanese women.. Journal of Clinical Oncology. 37(15_suppl). e13045–e13045. 1 indexed citations
10.
Haddad, Fadi, et al.. (2019). <p>Triple-negative breast cancer: current perspective on the evolving therapeutic landscape</p>. International Journal of Women s Health. Volume 11. 431–437. 119 indexed citations
11.
Ghosn, Marwan, Roland Eid, Hamdy A. Azim, et al.. (2019). OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell Carcinoma. Journal of Global Oncology. 5(5). 1–10. 8 indexed citations
12.
Haddad, Fadi, et al.. (2019). Seizures in Cancer Patients: a Vast Spectrum of Etiologies. Future Neurology. 14(4). 1 indexed citations
13.
Moujaess, Elissar, Fadi Haddad, Roland Eid, & Hampig Raphaël Kourié. (2019). The Emerging Use of Immune Checkpoint Blockade in the Adjuvant Setting for Solid Tumors: A Review. Immunotherapy. 11(16). 1409–1422. 34 indexed citations
14.
Hindy, Joya-Rita, et al.. (2018). Bladder cancer knowledge in the Lebanese population: When ignorance could be harmful. Bulletin du Cancer. 105(10). 857–861. 6 indexed citations
15.
Saleh, Khalil, et al.. (2018). New developments in the management of head and neck cancer &ndash; impact of pembrolizumab. Therapeutics and Clinical Risk Management. Volume 14. 295–303. 62 indexed citations
16.
Kourié, Hampig Raphaël, Ziad Bakouny, Roland Eid, Fadi Haddad, & Joseph Kattan. (2018). The Merit of Tyrosine Kinase Inhibitors in the Adjuvant Setting of High-Risk Renal Cell Carcinoma: A Meta-Analysis. Future Oncology. 14(9). 829–835. 2 indexed citations
17.
Haddad, Fadi, et al.. (2018). Prognostic and Predictive Biomarkers in Nonmetastatic Colorectal Cancers. Future Oncology. 14(21). 2097–2102. 5 indexed citations
18.
Kourié, Hampig Raphaël, et al.. (2016). Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?. Asian Pacific Journal of Cancer Prevention. 17(1). 215–217. 3 indexed citations
20.
Deinard, Amos S., Roland Eid, Kenneth K. Kídd, et al.. (1996). Conserved regulatory element involved in the early onset of Hoxb6 gene expression. Developmental Dynamics. 205(1). 73–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026